No Thumbnail

Is Africa Ready for PrEP?

Adebisi Ademola Alimi (Updated 08APR11) – One of the biggest breakthrough in HIV clinical research, since the outbreak of the epidemic 30 years ago, is the recent success in a clinical trial of a new HIV prevention approach based on the daily use of the

PrEP: for whom are these pills?

The results of the iPrEX study announced in November 2010 have brought some hope back into the field of HIV prevention. The clinical trial,which investigated the effectiveness of Pre-Exposure Prophylaxis mostly amongst men who have sex with men (MSM), showed that daily dosing of the

Switch to our mobile site